FDMT
Medium conviction4D Molecular Therapeutics, Inc.
Healthcare · NASDAQ
$673.3M mkt cap
Brief updated Jun 30, 2026
4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company that engineers therapeutic agents by leveraging its proprietary adeno-associated virus (AAV) vector technology. The company's developmental efforts are concentrated across a trio of therapeutic fields: ophthalmology (eye condit
FDMT is a medium-conviction name in Healthcare
FDMT sits at the intersection of key themes currently active in the market. The scoring engine rates it medium based on how well the active market forces line up with its business, plus available fundamental data. Financial metrics and analyst consensus provide additional context.
Why now
The market forces active right now are aligned with the company's core business exposure. The timing reflects the intersection of theme strength and available catalyst data.
Key risks
Data availability limits full scoring across all dimensions. Market forces can reverse rapidly; theme exposure does not guarantee the price follows. Fundamental valuation data may not reflect the most recent quarterly results.
What to watch
Monitor conviction score changes, especially the macro and analyst dimensions. Earnings guidance updates and analyst consensus shifts are the primary near-term catalysts.
'Third Iran-Linked Crude Carrier Crosses US Blockade Toward Asia' - Bloomberg
A third Iran-linked crude carrier has crossed the US blockade toward Asia, potentially signaling a breach in US sanctions and impacting global oil supply dynamics. This development could have significant implications for the global energy market and geopolitical tensions.
Jun 17, 2026
President Trump Says Reports Of A $300B Fund As Part Of An Iran Deal Is False; U.S. Is Not Investing In That; Iran MoU Isn't Final, If I Don't Like It, We Will Go Back To Dropping Bombs
President Trump denies reports of a $300B fund as part of an Iran deal, stating the US is not investing in it, and threatens to resume military action if the deal is not to his liking, escalating tensions with Iran.
Jun 17, 2026
'Third Iran-Linked Crude Carrier Crosses US Blockade Toward Asia' - Bloomberg
A third Iran-linked crude carrier has crossed the US blockade toward Asia, potentially signaling an escalation of the cat-and-mouse game between Iran and the US over oil exports, which could impact global oil supplies and prices.
Jun 17, 2026
GM, Lockheed in talks to collaborate as US scales weapons stockpile
The US is scaling up its weapons stockpile, with GM and Lockheed in talks to collaborate, indicating a potential increase in defense spending and geopolitical tensions. This move could have implications for the global military balance and trade relationships.
Jun 17, 2026
Earnings surprises
-4.1%
2026-05
+181.1%
2026-03
+1.0%
2025-11
-11.4%
2025-08
-2.4%
2025-05
Generated Tue, 30 Jun 2026 05:01:16 GMT by Decifer intelligence engine. For informational purposes only — not investment advice. Decifer Intelligence Hub.